Dexco 과거 순이익 실적
과거 기준 점검 0/6
Dexco의 수입은 연평균 -41.2%의 비율로 감소해 온 반면, Forestry 산업은 수입이 연평균 1.5% 감소했습니다. 매출은 연평균 1.3%의 비율로 증가해 왔습니다. Dexco의 자기자본이익률은 1%이고 순이익률은 0.1%입니다.
핵심 정보
-41.19%
순이익 성장률
-41.80%
주당순이익(EPS) 성장률
| Forestry 산업 성장률 | 45.90% |
| 매출 성장률 | 1.27% |
| 자기자본이익률 | 1.04% |
| 순이익률 | 0.10% |
| 다음 순이익 업데이트 | 06 Aug 2026 |
최근 과거 실적 업데이트
분석 기사 • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...분석 기사 • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...분석 기사 • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Recent updates
내러티브 업데이트 • Jun 01
DXCO3: Higher Margin Outlook And Governance Reset Will Support Upside
Analysts have adjusted their R$ price target for Dexco, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that keep fair value around R$9,00 while refining the risk and earnings profile behind that estimate. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 UTC, focused on board and executive appointments.분석 기사 • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
내러티브 업데이트 • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.내러티브 업데이트 • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.내러티브 업데이트 • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
내러티브 업데이트 • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.내러티브 업데이트 • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).내러티브 업데이트 • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).내러티브 업데이트 • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.내러티브 업데이트 • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).분석 기사 • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...내러티브 업데이트 • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.분석 기사 • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...내러티브 업데이트 • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.분석 기사 • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...분석 기사 • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...내러티브 업데이트 • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.분석 기사 • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...분석 기사 • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
새로운 내러티브 • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.분석 기사 • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...분석 기사 • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...분석 기사 • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...분석 기사 • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...분석 기사 • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...분석 기사 • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...분석 기사 • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...분석 기사 • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...분석 기사 • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...분석 기사 • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...분석 기사 • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...분석 기사 • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...분석 기사 • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...매출 및 비용 세부 내역
매출 및 비용 세부 내역
Dexco가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 8,365 | 9 | 1,516 | 0 |
| 31 Dec 25 | 8,249 | 1 | 1,530 | 0 |
| 30 Sep 25 | 8,216 | 111 | 1,530 | 0 |
| 30 Jun 25 | 8,327 | 193 | 1,581 | 0 |
| 31 Mar 25 | 8,201 | 258 | 1,563 | 0 |
| 31 Dec 24 | 8,235 | 172 | 1,545 | 0 |
| 30 Sep 24 | 8,119 | 337 | 1,533 | 0 |
| 30 Jun 24 | 7,649 | 542 | 1,471 | 0 |
| 31 Mar 24 | 7,607 | 602 | 1,475 | 0 |
| 31 Dec 23 | 7,383 | 790 | 1,428 | 0 |
| 30 Sep 23 | 7,415 | 812 | 1,381 | 0 |
| 30 Jun 23 | 7,808 | 668 | 1,392 | 0 |
| 31 Mar 23 | 8,068 | 680 | 1,415 | 0 |
| 31 Dec 22 | 8,487 | 756 | 1,459 | 0 |
| 30 Sep 22 | 8,757 | 1,128 | 1,492 | 0 |
| 30 Jun 22 | 8,773 | 1,229 | 1,446 | 0 |
| 31 Mar 22 | 8,533 | 1,776 | 1,337 | 0 |
| 31 Dec 21 | 8,170 | 1,725 | 1,310 | 0 |
| 30 Sep 21 | 7,813 | 1,446 | 1,164 | 0 |
| 30 Jun 21 | 7,414 | 1,315 | 1,127 | 0 |
| 31 Mar 21 | 6,486 | 574 | 1,065 | 0 |
| 31 Dec 20 | 5,880 | 454 | 1,037 | 0 |
| 30 Sep 20 | 5,472 | 437 | 1,018 | 0 |
| 30 Jun 20 | 5,003 | 341 | 990 | 0 |
| 31 Mar 20 | 5,101 | 434 | 980 | 0 |
| 31 Dec 19 | 5,012 | 406 | 948 | 0 |
| 30 Sep 19 | 4,789 | -21 | 919 | 0 |
| 30 Jun 19 | 4,993 | 327 | 929 | 0 |
| 31 Mar 19 | 5,016 | 425 | 919 | 0 |
| 31 Dec 18 | 4,949 | 432 | 899 | 0 |
| 30 Sep 18 | 4,789 | 658 | 869 | 0 |
| 30 Jun 18 | 4,296 | 365 | 825 | 0 |
| 31 Mar 18 | 4,045 | 223 | 807 | 0 |
| 31 Dec 17 | 3,991 | 185 | 801 | 0 |
| 30 Sep 17 | 3,917 | 125 | 785 | 0 |
| 30 Jun 17 | 3,864 | 72 | 761 | 0 |
| 31 Mar 17 | 3,960 | 47 | 761 | 0 |
| 31 Dec 16 | 3,910 | 24 | 752 | 0 |
| 30 Sep 16 | 3,836 | 50 | 757 | 0 |
| 30 Jun 16 | 3,911 | 48 | 767 | 0 |
| 31 Mar 16 | 3,863 | 85 | 754 | 0 |
| 31 Dec 15 | 3,963 | 183 | 755 | 0 |
| 30 Sep 15 | 4,048 | 221 | 731 | 0 |
| 30 Jun 15 | 4,064 | 275 | 716 | 0 |
양질의 수익: DXCO3는 R$18.3M 규모의 큰 일회성 손실이 있어 31st March, 2026까지 지난 12개월 재무 결과에 영향을 미쳤습니다.
이익 마진 증가: DXCO3의 현재 순 이익률 (0.1%)은 지난해 (3.1%)보다 낮습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: DXCO3의 수익은 지난 5년 동안 연평균 41.2% 감소했습니다.
성장 가속화: DXCO3은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.
수익 대 산업: DXCO3은 지난 1년 동안 수익이 감소(-96.7%)하여 Forestry 업계 평균(-6.9%)과 비교하기 어렵습니다.
자기자본이익률
높은 ROE: DXCO3의 자본 수익률(1%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/10 06:26 |
| 종가 | 2026/06/09 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Dexco S.A.는 15명의 분석가가 다루고 있습니다. 이 중 10명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |